Kelly Broderick

Senior Director, Medical Strategy

Greater Cleveland

About

Experience

  • Apellis Pharmaceuticals (Full-time · 6 yrs 2 mos)
    • Senior Director, Medical Strategy
      Nov 2025 - Present · 9 mos

    • Senior Director, US Medical Affairs
      Sep 2024 - Nov 2025 · 1 yr 3 mos

      U.S. Medical Strategy Lead, Ophthalmology

    • Director, Medical Value & Evidence Generation
      Aug 2021 - Sep 2024 · 3 yrs 2 mos

  • Director, Health Economics & Outcomes Research Field at Sage Therapeutics
    2018 - 2020 · 2 yrs

  • Associate Director, Health Economics & Outcomes Research at Sunovion Pharmaceuticals Inc.
    2015 - 2018 · 3 yrs

  • Cubist Pharmaceuticals (5 yrs 1 mo)
    • Senior Manager, Health Economics & Outcomes Research
      2014 - 2015 · 1 yr

      - Developed and executed HEOR strategy for in-line and development products - Directed the design and execution of product registries - Led Advisory Board meetings to develop protocols for key real-world data generation initiatives - Designed economic models for field use and publication in collaboration with 3rd party vendors

    • Manager, Health Economics & Outcomes Research
      2012 - 2014 · 2 yrs

      - Designed, developed, and managed HEOR projects for both in-line and development products - Collaborated with product development teams to integrate HEOR endpoints into clinical trials - Generated HEOR related field materials for use with external customers - Presented HEOR strategy for Cubist products to clinical experts at scientific advisory boards

    • Post Doctoral Fellow- Medical Affairs & HEOR
      2010 - 2012 · 2 yrs

      Focus in Drug Information and Health Economics & Outcomes Research

  • Adjunct Assistant Professor at MCPHS
    2010 - 2012 · 2 yrs

    - Developed and presented lectures for various pharmacy electives - Developed and submitted scientific manuscripts for publication - Assisted in development, recruitment, and interviewing of fellowship candidates